Baseline Tumor Immune Cell Infiltration and Activation can Predict Checkpoint Inhibitor Pneumonitis in Lung Cancer Patients
Por:
Bracht, J, Viteri, S, Aguilar, A, Garcia, JJ, Huang, C, Potie, N, Aldeguer, E, Gimenez-Capitan, A, Rodriguez, S, Roman, R, Warren, S, Rosell, R, Molina-Vila, MA and Gonzalez-Cao, M
Publicada:
1 mar 2021
Resumen:
Filiaciones:
Bracht, J:
Pangaea Oncol, Lab Mol Biol, Barcelona, Spain
Viteri, S:
Quiron Dexeus Univ Inst, Inst Oncol Rosell, Barcelona, Spain
Aguilar, A:
Quiron Dexeus Univ Inst, Inst Oncol Rosell, Barcelona, Spain
Garcia, JJ:
Quiron Dexeus Univ Inst, Inst Oncol Rosell, Barcelona, Spain
Huang, C:
NanoString Technol, Seattle, WA USA
Potie, N:
Univ Granada, Dept Genet, Granada, Spain
Aldeguer, E:
Pangaea Oncol, Lab Mol Biol, Barcelona, Spain
Gimenez-Capitan, A:
Pangaea Oncol, Lab Mol Biol, Barcelona, Spain
Rodriguez, S:
Pangaea Oncol, Lab Mol Biol, Barcelona, Spain
Roman, R:
Pangaea Oncol, Lab Mol Biol, Barcelona, Spain
Warren, S:
NanoString Technol, Seattle, WA USA
:
Inst Hlth Sci Res Germans Trias & Pujol Igtp, Lab Canc Biol, Badalona, Spain
Molina-Vila, MA:
Pangaea Oncol, Lab Mol Biol, Barcelona, Spain
Gonzalez-Cao, M:
Quiron Dexeus Univ Inst, Inst Oncol Rosell, Barcelona, Spain
|